RE: On the global front..............19 Mar 2021 11:45
Apollon Formularies, Chief Executive Officer, Dr. , said: Stephen Barnhill
“We are delighted to be coming to market at such an important time for medical cannabis across the . The reaction to newly listed cannabis-related businesses has been remarkable, and we look forward to bringing Apollon, with its full suite of licences and THC inclusive formulations, to the market.UKLondon
“Apollon’s strong research and development ability will make us one of the few listed cannabis companies in that is able to treat patients with formulas inclusive of THC, and the licences held in mean that all our formulas are backed by medically supervised treatments. Our conditional fundraise of £2,500,000, as announced on 23 February, has shown a strong appetite for our company and we are pleased that we are able to provide the market with a truly unique investment opportunity.” EuropeJamaica
https://www.proactiveinvestors.co.uk/LON:AFRI/AfriAg-Global-plc/rns/950201